Drug intelligence / Profile preview

fipronil + cyphenothrin

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Topical
01

Overview

**Fipronil + cyphenothrin** is a topical combination ectoparasiticide approved for use in dogs to control and treat infestations by fleas, ticks, and chewing lice[1][5][6]. The main brand name is Parastar Plus. It may also be effective as a treatment for sarcoptic mange and is sometimes used off-label for other ectoparasitic conditions in dogs[1]. - **Mechanism of action:** - Fipronil acts primarily as an insecticide by blocking GABA-gated chloride channels in nerve cells, resulting in hyperexcitation and death of the target parasites[5][6]. - Cyphenothrin is a synthetic pyrethroid that targets voltage-sensitive sodium channels, holding them open longer and causing persistent neuronal excitation leading to paralysis and death of insects[5][6]. - This combination exhibits broad-spectrum activity, providing rapid (effect within minutes) and persistent protection (up to 4 weeks) against targeted ectoparasites. - The product demonstrates high selectivity for insect targets over mammals, and safety data show minimal adverse effects in dogs when used according to instructions[5][6]. - Developed and manufactured by Merial (now part of Boehringer Ingelheim)[7].

Brand names
Parastar Plus
Other names
fipronil with cyphenothrin
02

Targets

GluCl (Glutamate-gated chloride channel)NaV (Voltage-gated sodium channels)GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on fipronil + cyphenothrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fipronil + cyphenothrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call